[1]
“Die heilmittelrechtliche Qualifikation von nanotechnologischen drug-delivery-Produkten”, ea, vol. 2016, no. 2, pp. 14–22, Mar. 2018, Accessed: May 03, 2024. [Online]. Available: https://www.ex-ante.ch/index.php/exante/article/view/47